Program Purpose ACRIN is pleased to announce an opportunity for junior faculty (assistant professors and instructors within the first seven years post-fellowship or post-training) to carry out an ancillary research project using the ACRIN imaging archive and associated case data. Available images and data were collected during the conduct of ACRIN clinical trials and subject to ACRIN s quality assurance processes. The initiative is intended to introduce junior faculty to ACRIN and to engage them in an ACRIN research endeavor that can be completed within a relatively short timeframe and will result in a publication. This program is made available through the ACRIN Fund for novation. Award Specifics dividual award: $10,000 Number of awards: 5 Application deadline: October 15, 2014 Anticipated award date: November 15, 2014 Program Description Image and Data Resource Award recipients will have access to data ACRIN has compiled from its conduct of a select set of multicenter clinical trials over the past 15 years. While oncologic imaging is ACRIN s primary research focus, clinical trials related to arthritis, Alzheimer s disease, and cardiovascular disease have also been conducted. A list of specific ACRIN trials which will make data available to researchers under this announcement is included at the end of the announcement. Types of Research ACRIN trial data (images, clinical, and outcome data) form a rich resource for further investigation. Potential secondary research opportunities include: o Developing new image analysis approaches for diagnosis, characterization of disease, or prediction of outcome; o Studying the prevalence of findings in a specified cohort; o Analyzing trial data against alternate endpoints; o Surveying image quality or radiation dose. Page 1 of 2
Data Analysis Support with the data analysis plan is provided by the ACRIN Biostatistics Center and a statistician will be assigned to each awarded project at the time of the award. Award recipients will be responsible for performing the data analysis, and the ACRIN statistician will consult with the investigator on the final manuscript. Review Criteria Applications will be scored on criteria to include: 1. Overall scientific merit 2. Potential for affect on clinical care 3. Prospects for using data to support some aspect of a future ACRIN trial 4. Feasibility to carry out with existing archived data and images 5. Feasibility to complete within approximately one year from the date of award notice Application Process The Young vestigator itiative Application should not exceed 2 pages (using typical NIH format requirements for fonts and margins). It should include a brief background, specific aims, and a brief description of methods. Description of methods should include the specific ACRIN data to be used in the study. Data collected for ACRIN trials can be found in the case report forms (CRFs) available for each protocol on the ACRIN Web site. An example can be found at: http://www.acrin.org/protocolsummarytable/protocol6673/6673dataforms.aspx. Available preliminary data may be included in the background section; however, preliminary data are not required. Literature references should be included and do not count in the 2 page limit. The following application materials are to be emailed to Tina Taylor: ttaylor@acr.org. 1. The Young vestigator itiative Application 2. A letter of support from the applicant s department chair 3. A cover letter that includes the research project s name and the applicant s name and contact information addressed to: Mitchell D. Schnall, MD, PhD ACRIN Network Chair 1818 Market Street Suite 1600 Philadelphia, PA 19103 Applications must be received no later than October 15, 2014. For questions, contact Tina Taylor (434-296-3102) Page 2 of 2
ACRIN Protocols ABDOMINAL PROTOCOLS 6656 Colon Cancer: Diagnostic Accuracy of CT Colonography C. Daniel Johnson, MD 117 6659 Prostate Cancer: Staging with MRI and MRS Jeffrey C. Weinreb, MD 134 6664 Colorectal Cancer: Screening with CT Colonography C. Daniel Johnson, MD 2617 6665* Malignant GI Stromal Tumors: Treatment Monitoring with PET Burton Eisenberg, MD (RTOG Chair) Annick Van den Abbeele, MD (ACRIN PI) 63 6673 Liver Cancer: Treatment with RF Ablation Gerald Dodd, III, MD Radiofrequency Ablation Analysis 51 6687* Biomarker: 18F-Fluoride PET as a Biomarker for Prostate Cancer and Bone Metastases Evan Y. Yu, MD Analysis 18 BREAST PROTOCOLS 4006 Comparison of Full-Field Digital Mammography with Digital Breast Tomosynthesis in Screening Call-Back Rate Emily F. Conant, MD Mammography Accrual Complete 558 6652 Screening with Digital Mammography (DMIST) Etta Pisano, MD Mammography 49529 6657* Treatment Monitoring with Dynamic MRI Laura J. Esserman, MD, MBA (CLAGB Chair) Nola M. Hylton, PhD (ACRIN PI) Analysis 356 6666 Screening with Ultrasound Wendie A. Berg, MD, PhD Ultrasound 2809 6667 Screening of Contralateral Breast with MRI Constance Lehman, MD, PhD 1007 6691 Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic (DOSI) Bruce J. Tromberg, PhD Diffuse Optical Spectroscopic 60 Page i
CARDIOVASCULAR PROTOCOLS 4005 CT Coronary Angiogram vs Traditional Care for Low-Risk ED Pts with Potential Acute Coronary Syndromes Study Co-Principal vestigators: Harold Litt, MD, PhD Judd Hollander, MD 1393 4007 RESCUE: Randomized Evaluation of Patients with Stable Angina Comparing Utilization of Diagnostic Examinations Arthur Stillman, MD, PhD 1050 GYNECOLOGICAL PROTOCOLS 6651* Cervical Cancer: Staging with CT and MRI Hedvig Hricak, MD, PhD 208 6671* Cervical and Endometrial Cancers: Staging with PET/CT Michael Gold, MD (GOG PI) Mostafa Atri, MD (ACRIN PI) Analysis 384 6682 Cervical Cancer: 64Cu-ATSM PET/CT Assessment of Tumor Hypoxia Farrokh Dehdashti, MD 73 6695* Ovarian Cancer: Evaluating Perfusion CT as Prognostic dicator a sub-study of GOG 0262 Robert Coleman, MD(GOG PI) Chaan Ng, MD (ACRIN Co-PI) Ting Yim Lee, PhD (ACRIN Co-PI) Analysis 120 NEUROSCIENCE PROTOCOLS 4003 Alzheimer s: Evaluation of a Novel PET Radiopharmaceutical to Identify Patients with Alzheimer s Disease Steven E. Arnold, MD 32 Page ii
4004 Alzheimer s: Evaluation of a Novel PET Radiopharmaceutical to Identify Patients with Alzheimer s Disease James Mountz, MD, PhD Analysis 24 OTHER PROTOCOLS 4001 Knee Articular Cartilage Damage in Osteoarthritis: MRI Image Markers Timothy J. Mosher, MD 53 6660 Pediatric Malignancy: Staging with Whole-Body MRI Marilyn Siegel, MD 192 6661 Bone Met Ablation: Radiofrequency Ablation of Bone Metastases Using CT Guidance Damian E. Dupuy, MD Radiofrequency Ablation 66 6680* Neuroendocrine carcinoma: ACRIN SPECT Component of the SWOG S0518 Carcinoid Treatment Trial James C. Yao, M.D., (SWOG Chair) Lale Kostakoglu, MD(ACRIN PI) SPECT 110 THORACIC PROTOCOLS 6654* National Lung Screening Trial Denise Aberle, MD 18894 6668* FDG-PET Assessment for Stage III Non- Small Cell Lung Cancer Mitchell Machtay, MD Analysis 251 6678 Evaluation of Treatment Response with PET Wolfgang Weber, MD Analysis 96 *Note: Additional permission from collaborating organization may need to be requested, depending upon data required project. These requests will be facilitated by ACRIN upon selection of the projects for approval. Page iii